147401 Improving time to treatment following heart attack for rural American Indian and Alaska Natives

Monday, November 5, 2007

J. Nell Brownstein, PhD , Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Mark A. Veazie, DrPH , Native American Cardiology Program, Indian Health Service, Flagstaff, AZ
Eric A. Brody, MD, FACC , Native American Cardiology Program, Indian Health Service, Tucson, AZ
James M. Galloway, MD FACP, FACC , US Health and Human Services, Chicago, IL
Ellen Sommer, MBA , National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Bethesda, MD
Theresa C. Long , National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Bethesda, MD
Erin McDonald Bicknell , State Health Alliances, American Heart Association, Albuquerque, NM
Crystelle Fogle , Montana Cardiovascular Health Program, Montana Dept. of Public Health & Human Services, Helena, MT
Carol White , Alaska Division of Public Health, Heart Disease and Stroke Prevention Program, Juneau, AK
Marcia O'Leary, RN , Missouri Breaks Indian Research Inc., Timber Lake, SD
Sue Sherwood , Missouri Breaks Indian Research Inc., Timber Lake, SD
Carla Rae Marshall , Cheyenne River Sioux Tribe, Media Department, Rapid City, SD
Arlene Marshall , Cheyenne River Sioux Tribe, Health Education Department, Rapid City, ND
Clark H. Denny, PhD , Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Lazette Lawton , Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Every year, more than 1 million Americans have a first or recurrent heart attack/myocardial infarction (MI) and about one-third of these will be fatal. Early recognition of MI by both the victim and bystanders, followed by prompt cardiac emergency care, has a direct effect on patient outcomes.

Data from the National MI Registry show that American Indians/Alaska Natives (AI/AN) experience the greatest disparity in time to treatment. Data from the Native American Cardiology Program show that rural American Indians presenting with acute MI have significant delays in time to treatment compared with the national average, thus severely limiting their treatment options.

We sought to gain an understanding of the barriers related to these delays by obtaining information through independent, semi-structured telephone interviews with key informants (tribal health care providers and community leaders) and community focus groups. Participants represent three U.S. regions: the Great Plains, the Southwest, and Alaska. Information obtained from participants includes their beliefs, perceptions, and behaviors affecting these delays. To address the barriers that contribute to treatment delays, culturally tailored and clear communications messages, identified messengers, and methods of delivery that have the potential to reduce time to treatment will be shared.

This project was developed as an initiative of the Healthy People 2010 Heart Disease and Stroke Partnership, a consortium of multiple federal agencies and the American Heart Association. Planning, implementation, and evaluation of the project are being guided by an advisory group made up of tribal and state representatives and members of the Partnership.

Learning Objectives:
1. Summarize the current disparities in time to treament following a heart attack in rural AI/AN populations. 2. Describe at least two critical barriers that keep American Indians and Alaskan Natives (AI/AN)from seeing immediate medical attention while having a heart attack. 2. Identify the perfered styles of communication of messages by rural AI/NA populations. 3. Identify two methods of delivering messages that prompt urgent action to the rural AI/AN populations.

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.